OJMC  Vol.4 No.2 , June 2014
Efficient Utilization of 6-Aminouracil to Synthesize Fused and Related Heterocyclic Compounds and Their Evaluation as Prostate Cytotoxic Agents with Cathepsin B Inhibition
Abstract: 6-aminouracil 1 was utilized to introduce different heterocyclic rings at C-6 position through various synthetic strategies. The synthesized compounds bear rings that are either directly attached to the uracil back bone as in compounds 6, 12a-c and 15, or attached through an amino bridge as compounds 3a-c, 5a, b, 7a, b, 9 and 10, or through an imino bridge as compound 18. Also, compounds 4, 8, 11a-c, 14, 16 and 17 bearing biologically active side chains were synthesized. In addition to, compounds 13, 19, 20, 21 and 22 bear fused rings to the uracil backbone. All synthesized compounds were evaluated for their anticancer activity against prostate PC3 cell line using in-vitro sulforhodamine-B (SRB) method, from which compounds 3a, c, 4, 5a, b, 6, 7a, b, 11a-c, 12a, b, 17 and 20 were the most active. These active compounds were further evaluated for their ability to inhibit cathepsin B enzyme by using enzyme-linked immunosorbent assay, which revealed that compounds 5a, b, 7a, 11a, 12a and 17 exhibited more than 50% inhibition of cathepsin B. Among which the phenyl thiourea derivative 17 was the most active exhibiting 82.3% inhibition, while the reference doxorubicin exerted 18.7% inhibition.
Cite this paper: Sarg, M. and El-Shaer, S. (2014) Efficient Utilization of 6-Aminouracil to Synthesize Fused and Related Heterocyclic Compounds and Their Evaluation as Prostate Cytotoxic Agents with Cathepsin B Inhibition. Open Journal of Medicinal Chemistry, 4, 39-60. doi: 10.4236/ojmc.2014.42003.

[1]   El-Deeb, I.M. and Lee, S.H. (2010) Design and Synthesis of New Anticancer Pyrimidines with Multiple-Kinase Inhibitory Effect. Bioorganic & Medicinal Chemistry, 18, 3860-3874.

[2]   Jemal, C., Siegel, R., Xu, J. and Ward, E. (2010) Cancer Statistics. Ca—A Cancer Journal for Clinicians, 60, 277-300.

[3]   Merino, M., Pinto, A., González, R. and Espinosa, E. (2011) Antiangiogenic Agents and Endothelin Antagonists in Advanced Castration Resistant Prostate Cancer. European Journal of Cancer, 47, 1846-1851.

[4]   VanCleave, T.T., Moore, J.H., Benford, M.L., Brock, G.N., Kalbfleisch, T., Baumgartner, R.N., Lillard Jr., J.W., Kittles, R.A. and Kidd, L.C.R. (2009) Interaction among Variant Vascular Endothelial Growth Factor (VEGF) and Its Receptor in Relation to Prostate Cancer Risk. The Prostate, 70, 341-352.

[5]   Folkman, J. (1972) Angiogenesis in Psoriasis: Therapeutic Implications. Journal of Investigative Dermatology, 59, 40-43.

[6]   Giavazzi, R. and Taraboletti, G. (1999) Angiogenesis and Angiogenesis Inhibitors in Cancer. Forum (Genova), 9, 261-272.

[7]   Kroemer, G. and Jaattela, M. (2005) Lysosomes and Autography in Cell Death Control. Nature Reviews Cancer, 5, 886-897.

[8]   Oliveira, C.R., Barbosa, C.M.V., Nascimento, F.D., Lanetzki, C.S., Meneghin, M.B., Pereira, F.E.G., Paredes-Gamero, E.J., Ferreira, A.T., Rodrigues, T., Queiroz, M.L.S., Caires, A.C.F., Tersariol, I.L.S. and Bincoletto, C. (2009) Pre-Clinical Antitumour Evaluation of Biphosphinic Palladacycle Complex in Human Leukaemia Cells. Chemico-Biological Interactions, 177, 181-189.

[9]   Reinheckel, T., Peters, C., Krüger, A., Turk, B. and Vasiljeva, O. (2012) Differential Impact of Cysteine Cathepsins on Genetic Mouse Models of De Novo Carcinogenesis: Cathepsin B as Emerging Therapeutic Target. Frontiers in Pharmacology, 3, 133.

[10]   Mohamed, M.M. and Sloane, B.F. (2006) Cysteine Cathepsins: Multifunctional Enzymes in Cancer. Nature Reviews Cancer, 6, 764-775.

[11]   Gocheva, V. and Joyce, J.A. (2007) Cysteine Cathepsins and the Cutting Edge of Cancer Invasion. Cell Cycle, 6, 60-64.

[12]   Vasiljeva, O., Reinheckel, T., Peters, C., Turk, D., Turk, V. and Turk, B. (2007) Emerging Roles of Cysteine Cathepsins in Disease and Their Potential as Drug Targets. Current Pharmaceutical Design, 13, 387-403.

[13]   Doxakis, A., Maria, A., Savvas, P. and Zafiroula, I.K. (2013) Assessment of the Roles of Cathepsins B, H and L in the Progression of Colorectal Cancer. Journal of Cancer Therapy, 4, 1-7.

[14]   Foghsgaard, L., Wissing, D., Mauch, D., Lademann, U., Bastholm, L., Boes, M., Elling, F., Leist, M. and Jaattela, M. (2001) Cathepsin B Acts as a Dominant Execution Protease in Tumour Cell Apoptosis Induced by Tumour Necrosis Factor. The Journal of Cell Biology, 153, 999-1010.

[15]   Beckham, T.H., Lu, P., Cheng, J.C., Zhao, D., Turner, L.S., Zhang, X., Hoffman, S., Armeson, K.E., Liu, A., Marrison, T., Hannun, Y.A. and Liu, X. (2012) Acid Ceramidase-Mediated Production of Sphingosine 1-Phosphate Promotes Prostate Cancer Invasion through Upregulation of Cathepsin B. International Journal of Cancer, 131, 2034-2043.

[16]   El Gemeie, G.H. (2003) Thioguanine, Mercaptopurine: Their Analogs and Nucleosides as Antimetabolites. Current Pharmaceutical Design, 9, 2627-2642.

[17]   Parker, W.B., Secrist, J. and Waud, W.R. (2004) Purine Nucleoside Antimetabolites in Development for the Treatment of Cancer. Current Opinion in Investigational Drugs, 5, 592-596.

[18]   Nussbaumer, S., Bonnabry, P., Veuthey, J.L. and Fleury-Souverain, S. (2011) Analysis of Anticancer Drugs: A Review. Talanta, 85, 2265-2289.

[19]   Heidelberger, C. (1984) Pyrimidine and Pyrimidine Antimetabolites in Cancer Medicine. Lea and Febiger, Philadelphia, 801-824.

[20]   Kundu, N.G., Das, P., Balzarini, J. and De Clercq, E. (1997) Palladium-Catalyzed Synthesis of [E]-6-(2-Acylvinyl) Uracils and [E]-6-(2-Acylvinyl)-1-[(2-hydroxyethoxy)methyl]uracils—Their Antiviral and Cytotoxic Activities. Bioorganic & Medicinal Chemistry, 5, 2011-2018.

[21]   Sigmond, J. and Peters, G.J. (2005) Pyrimidine and Purine Analogues, Effects on Cell Cycle Regulation and the Role of Cell Cycle Inhibitors to Enhance Their Cytotoxicity. Nucleosides, Nucleotides and Nucleic Acids, 24, 1997-2022.

[22]   Prekupec, S., Makuc, D., Plavec, J., Suman, L., Kralj, M., Pavelic, K., Balzarini, J., De Clercq, E., Mintas, M. and Raic-Malic, S. (2007) Novel C-6 Fluorinated Acyclic Side Chain Pyrimidine Derivatives: Synthesis, 1H and 13C NMR Conformational Studies, and Antiviral and Cytostatic Evaluations. Journal of Medicinal Chemistry, 50, 3037-3045.

[23]   Gazivoda, T., Sokcevic, M., Kralj, M., Suman, L., Pavelic, K., De Clercq, E., Andrei, G., Snoeck, R., Balzarini, J., Mintas, M. and Raic-Malic, S. (2007) Synthesis and Antiviral and Cytostatic Evaluations of the New C-5 Substituted Pyrimidine and Furo[2,3-d]pyrimidine 4’,5’-Didehydro-L-ascorbic Acid Derivatives. Journal of Medicinal Chemistry, 50, 4105-4112.

[24]   Gazivoda, T., Raic-Malic, S., Marjanovic, M., Kralj, M., Pavelic, K., Balzarini, J., De Clercq, E. and Mintas, M. (2007) The Novel C-5 Aryl, Alkenyl, and Alkynyl Substituted Uracil Derivatives of L-Ascorbic Acid: Synthesis, Cytostatic, and Antiviral Activity Evaluations. Bioorganic & Medicinal Chemistry, 15, 749-758.

[25]   Spácilová, L., Dzubák, P., Hajdúch, M., Krupkováa, S., Hradil, P. and Hlavác, J. (2007) Synthesis and Cytotoxic Activity of Various 5-[Alkoxy-(4-nitro-phenyl)-methyl]uracils in Their Racemic Form. Bioorganic & Medicinal Chemistry Letters, 17, 6647-6650.

[26]   Kraljevic, T.G., Kristafor, S., Suman, L., Kralj, M., Ametamey, S.M., Cetina, M. and Raic-Malic, S. (2010) Synthesis, X-Ray Crystal Structure Study and Antitumoral Evaluations of 5,6-Disubstituted Pyrimidine Derivatives. Bioorganic & Medicinal Chemistry, 18, 2704-2712.

[27]   Lee, Y.S. and Kim, B.H. (2002) Heterocyclic Nucleoside Analogues: Design and Synthesis of Antiviral, Modified Nucleosides Containing Isoxazole Heterocycles. Bioorganic & Medicinal Chemistry Letters, 12, 1395-1397.

[28]   Lee, Y.S., Park, S.M. and Kim, B.H. (2009) Synthesis of 5-Isoxazol-5-yl-2’-deoxyuridines Exhibiting Antiviral Activity against HSV and Several RNA Viruses. Bioorganic & Medicinal Chemistry Letters, 19, 1126-1128.

[29]   Jakubiec, D. and Walczak, K.Z. (2011) A Convenient Synthesis of 5-(1,2,4-Oxadiazol-5-yl)pyrimidine-2,4(1H, 3H)- diones. Tetrahedron Letters, 52, 6890-6891.

[30]   Lee, Y.S., Park, S.M., Kim, H.M., Park, S.K., Lee, K., Lee, C.W. and Kim, B.H. (2009) C5-Modified Nucleosides Exhibiting Anticancer Activity. Bioorganic & Medicinal Chemistry Letters, 19, 4688-4691.

[31]   Soliman, R., Habib, N.S., Ismail, K., Moustafa, A., Sarg, M.T. and Fanaki, N.H. (2003) Synthesis of Novel Pyri- midine-2,4-diones and 2-Thioxopyrimidine-4-ones as Potential Anticancer and Antimicrobial Agents. Bollettino Chimico Farmaceutico, 142, 167-174.

[32]   Habib, N.S., Soliman, R., Ismail, K., Hassan, A.M. and Sarg, M.T. (2003) Synthesis of Novel Pyrimidines, 1,2,4-Tri- azolo[4,3-a]pyrimidin-7-ones and Pyrimidino[2,1-c][1,2,4]triazin-8-ones for Their Antimicrobial and Anticancer Activities. Bollettino Chimico Farmaceutico, 142, 396-405.

[33]   Cui, Z., Li, Y., Huang, J., Cui, J., Wang, R. and Yang, X. (2010) New Class of Potent Antitumour Acylhydrazone Derivatives Containing Furan. European Journal of Medicinal Chemistry, 45, 5576-5584.

[34]   Abdel-Hamid, H.F., Soliman, A., Helaly, F.M. and Ragab, S. (2011) Cytotoxic Potency and Induced Biochemical Parameters in Mice Serum of New Furan Derivatives against Liver Cancer Cell Line. Acta Poloniae Pharmaceutica, 68, 499-505.

[35]   Idhayadhulla, A., Kumar, R.S., Nasser, A.J.A. and Manilal, A. (2013) Synthesis of Some New Pyrrole and Pyridine Derivatives and Their Antimicrobial, Anticancer Activities. International Journal of Biological Chemistry, 7, 15-26.

[36]   Alsaid, M.S., El-Gazzar, M.G. and Ghorab, M.M. (2013) Anticancer Activity of Novel Thiophenes Containing a Biological Active Diphenyl Sulfone, Diazepine, Piperidine, Oxazepine, Acrylaldehyde and Sulfonamide Moieties. Drug Research, 63, 263-269.

[37]   Garg, V., Kumar, A., Chaudhary, A., Agrawal, S., Tomar, P. and Sreenivasan, K.K. (2013) Synthesis, Biological Evaluation and Molecular Docking Studies of 1,3-Benzoxazine Derivative as Potential Anticancer Agents. Medicinal Chemistry Research, 22, 5256-5266.

[38]   Lee, S.H., Kim, N., Kim, S.J., Song, J., Gong, Y.D. and Kim, S.Y. (2013) Anti-Cancer Effect of Quinoxaline Derivatives GK13 as a Transglutaminase 2 Inhibitor. Journal of Cancer Research and Clinical Oncology, 139, 1279-1294.

[39]   Bathula, S.N.P. and Vadla, R. (2011) Bioactivity of 1,4-Disubstituted-1,2,3-triazoles as Cytotoxic Agents against the Various Human Cell Lines. Asian Journal of Pharmaceutical and Clinical Research, 4, 66-67.

[40]   Kurumurthy, C., Rao, P.S., Swamy, B.V., Kumar, G.S., Rao, P.S., Narsaiah, B., Velatooru, L.R., Pamanji, R. and Rao, J.V. (2011) Synthesis of Novel Alkyltriazole Tagged Pyrido[2,3-d]pyrimidine Derivatives and Their Anticancer Activity. European Journal of Medicinal Chemistry, 46, 3462-3468.

[41]   El-Gaby, M.S.A., Ismail, Z.H., Abdel-Gawad, S.M., Aly, H.M. and Ghorab, M.M. (2009) Synthesis of Thiazolidine and Thiophene Derivatives for Evaluation as Anticancer Agents. Phosphorus, Sulfur and Silicon and the Related Elements, 184, 2645-2654.

[42]   Abu-Hashem, A.A., El-Shehry, M.F. and Badria, F.A. (2010) Design and Synthesis of Novel Thiophenecarbohydrazide, Thienopyrazole and Thienopyrimidine Derivatives as Antioxidant and Antitumour Agents. Acta Pharmaceutica, 60, 311-323.

[43]   Zhu, W.F., Zhai, X., Li, S., Cao, Y.Y., Gong, P. and Liu, Y.J. (2012) Synthesis and Cytotoxic Activity of Novel 2,6- Disubstituted-4-morpholinothieno[3,2-d]pyrimidines as Potent Anti-Tumour Agents. Chinese Chemical Letters, 23, 703-706.

[44]   Bernier, J.L., Henichart, J.P., Warin, V., Trentesaux, C. and Jardillier, J.C. (1985) 5-Cinnamoyl-6-aminouracil Derivatives as Novel Anticancer Agents: Synthesis, Biological Evaluation and Structure-Activity Relationships. Journal of Medicinal Chemistry, 28, 497-502.

[45]   Dabiri, M., Arvin-Nezhad, H., Khavasi, H.R. and Bazgir, A. (2007) A Novel and Efficient Synthesis of Pyrimido[4, 5-d]pyrimidine-2,4,7-trione and Pyrido[2,3-d:6,5-d]dipyrimidine-2,4,6,8-tetrone Derivatives. Tetrahydron, 63, 1770-1774.

[46]   Essa, F.B., Bazbouz, A. and Al-Lababidi, S. (2010) Preparation, Chemical and Biological Study of Acyclovir Analogue Starting from 6-Aminouracil. Oriental Journal of Chemistry, 26, 1281-1292.

[47]   Samai, S., Nandi, G.C., Chowdhury, S. and Singh, M.S. (2011) L-Proline Catalyzed Synthesis of Densely Functionalized Pyrido[2,3-d]pyrimidines via Three-Component One-Pot Domino Knoevenagel Aza-Diels-Alder Reaction. Tetrahydron, 67, 5935-5941.

[48]   Fargualy, A.M., Habib, N.S., Ismail, K.A., Hassan, A.M.M. and Sarg, M.T.M. (2013) Synthesis, Biological Evaluation and Molecular Docking Studies of Some Pyrimidine Derivatives. European Journal of Medicinal Chemistry, 66, 276-295.

[49]   Fathalla, O.A., Zeid, I.F., Haiba, M.E., Soliman, A.M., Abd-Elmoez, S.I. and El-Serwy, W.S. (2009) Synthesis, Antibacterial and Anticancer Evaluation of Some Pyrimidine Derivatives. World Journal of Chemistry, 4, 127-132.

[50]   Bondock, S., Khalifa, W. and Fadda, A.A. (2011) Synthesis and Antimicrobial Activity of Some New 4-Hetarylpyrazole and Furo[2,3-c]pyrazole Derivatives. European Journal of Medicinal Chemistry, 46, 2555-2561.

[51]   Alqasoumi, S.I., Ghorab, M.M., Ismail, Z.H., Abdel-Gawad, S.M., El-Gaby, M.S.A. and Aly, H.M. (2009) Novel Antitumor Acetamide, Pyrrole, Pyrrolopyrimidine, Thiocyanate, Hydrazone, Pyrazole, Isothiocyanate and Thiophene Derivatives Containing a Biologically Active Pyrazole Moiety. Arzneimittel Forschung, 59, 666-671.

[52]   Aly, H.M. (2011) Novel Pyrrolidinone and Pyrazolo[1,5-a][1,3,5]triazine Derivatives Bearing a Biologically Active Sulfamoyl Moiety as a New Class of Antitumor Agents. Monatshefte für Chemie—Chemical Monthly, 142, 935-941.

[53]   Shim, J.L., Niess, R. and Broom, A.D. (1972) Acylation of Some 6-Aminouracil Derivatives. The Journal of Organic Chemistry, 37, 578-581.

[54]   Gewald, K.J. (1966) Heterocyclen aus CH-aciden nitrilen. IV. Addition von Schwefelkohlenstoff an Alkyliden Malonitrile. Journal für Praktische Chemie, 31, 205-213.

[55]   Aly, H.M., Saleh, N.M. and Elhady, H.A. (2011) Design and Synthesis of Some New Thiophene, Thienopyrimidine and Thienothiadiazine Derivatives of Antipyrine as Potential Antimicrobial Agents. European Journal of Medicinal Chemistry, 46, 4566-4572.

[56]   Shingare, M.S. and Ingle, D.B. (1976) Synthesis of Pyrimidine Schiff Bases as Anticancer Agents. Journal of Indian Chemical Society, LIII, 1036-1037.

[57]   Mohamed, N.R., El-Saidi, M.M.T., Ali, Y.M. and Elnagdi, M.H. (2007) Utility of 6-Amino-2-thiouracil as a Precursor for the Synthesis of Bioactive Pyrimidine Derivatives. Bioorganic & Medicinal Chemistry, 15, 6227-6235.

[58]   Shingare, M.S. (1983) Synthesis of New Thiazolidinones from Pyrimidine Schiff Bases and Their Biological Activity. Indian Journal of Chemistry B, 22, 714-715.

[59]   Archana, Srivastava, V.K. and Kumar, A. (2002) Synthesis of Newer Thiadiazolyl and Thiazolidinoyl Quinazolin-4 (3H)-ones as Potential Anticonvulsant Agents. European Journal of Medicinal Chemistry, 37, 873-882.

[60]   Patel, N.B. and Patel, V.N. (2010) Synthesis, Antibacterial and Antifungal Activities of Novel Thiazolidinyl Sulfonamides of Quinazolin-4(3H)ones. Pharmaceutical Chemistry Journal, 44, 438-445.

[61]   Abdou, W.M., Fahmy, A.F.M. and Kamel, A.A. (2002) A Facile Synthesis of Pyrrolo[3,2-d]pyrimidines from 6-Azidouracils and Ylide Phosphoranes. Heteroatom Chemistry, 13, 357-365.

[62]   Pokhodylo, N.T., Matiychuk, V.S. and Obushak, M.D. (2009) Synthesis of Ethyl 4,5-Disubstituted 2-Azido-3-thio- phenecarboxylates and Use in the Synthesis of Thieno[3,2-e][1,2,3]triazolo[1,5-a]pyrimidin-5(4H)-ones. Tetrahydron, 65, 2678-2683.

[63]   Hafiz, I.S.A., Ramiz, M.M.M., Mahmoud, F.F. and Darwish, E.S. (2008) β-Enaminonitriles in Heterocyclic Synthesis: Synthesis of New Tetrahydropyridinetrione, Pyridopyrimidines, Pyridotriazines and Dihydropyridines. Journal of Chemical Sciences, 120, 339-345.

[64]   Rostom, S.A.F., El-Ashmawy, I.M., El Razik, H.A., Badr, M.H. and Ashour, H.M.A. (2009) Design and Synthesis of Some Thiazolyl and Thiadiazolyl Derivatives of Antipyrine as Potential Non-Acidic Anti-Inflammatory, Analgesic and Antimicrobial Agents. Bioorganic & Medicinal Chemistry, 17, 882-895.

[65]   Marugan, J.J., Zheng, W., Motabar, O., Southall, N., Goldin, E., Sidransky, E., Aungst, R.A., Liu, K., Sadhukhan, S.K. and Austin, C.P. (2010) Evaluation of 2-Thioxo-2,3,5,6,7,8-hexahydropyrimido[4,5-d]pyrimidine-4(1H)-one Analogues as GAA Activators. European Journal of Medicinal Chemistry, 45, 1880-1897.

[66]   Ding, R., He, Y., Xu, J., Liu, H., Wang, X., Feng, M., Qi, C., Zhang, J. and Peng, C. (2012) Preparation and Bioevaluation of 99mTc Nitrido Radiopharmaceuticals with Pyrazolo[1,5-a]pyrimidine as Tumor Imaging Agents. Medicinal Chemistry Research, 21, 523-530.

[67]   Moin, K., Demchik, L., Mai, J., Duessing, J., Peters, C. and Sloane, B.F. (2000) Observing Proteases in Living Cells. Advances in Experimental Medicine and Biology, 477, 391-401.

[68]   Frohlich, E., Schlagenhauff, B., Mohrle, M., Weber, E., Klessen, C. and Rassner, G. (2001) Activity, Expression, and Transcription Rate of the Cathepsins B, D, H, and L in Cutaneous Malignant Melanoma. Cancer, 91, 972-982.

[69]   Sinha, A.A., Quast, B.J., Wilson, M.J., Fernandes, E.T., Reddy, P.K., Ewing, S.L. and Gleason, D.F. (2002) Prediction of Pelvic Lymph Node Metastasis by the Ratio of Cathepsin B to Stefin A in Patients with Prostate Carcinoma. Cancer, 94, 3141-3149.

[70]   Bialas, A. and Kafarski, P. (2009) Proteases as Anti-Cancer Targets—Molecular and Biological Basis for Development of Inhibitor-Like Drugs against Cancer. Anti-Cancer Agents Medicinal Chemistry, 9, 728-762.

[71]   Lankelma, J., Voorend, D., Barwari, T., Koetsveld, J., Van der Spek, A., De Porto, A., Van Rooijen, G. and Van Noorden, C. (2010) Cathepsin L, Target in Cancer Treatment? Life Sciences, 86, 225-233.

[72]   Rothberg, J.M., Sameni, M., Moin, K. and Sloane, B.F. (2012) Live-Cell Imaging of Tumor Proteolysis: Impact of Cellular and Non-Cellular Microenvironment. Biochimica et Biophysica Acta (BBA)—Proteins and Proteomics, 1824, 123-132.

[73]   Van Damme, J., Struyf, S. and Opdenakker, G. (2004) Chemokine-Protease Interactions in Cancer. Seminars in Cancer Biology, 14, 201-208.

[74]   Green, K.A. and Lund, L.R. (2005) ECM Degrading Proteases and Tissue Remodeling in the Mammary Gland. BioEssays, 27, 894-903.

[75]   Joyce, J.A. and Pollard, J.W. (2009) Microenvironmental Regulation of Metastasis. Nature Reviews Cancer, 9, 239-252.

[76]   López-Otin, C. and Hunter, T. (2010) The Regulatory Crosstalk between Kinases and Proteases in Cancer. Nature Reviews Cancer, 10, 278-292.

[77]   Mason, S.D. and Joyce, J.A. (2011) Proteolytic Networks in Cancer. Trends in Cell Biology, 21, 228-237.

[78]   Turk, B., Turk, D.S. and Turk, V. (2012) Protease Signalling: The Cutting Edge. The EMBO Journal, 31, 1630-1643.

[79]   Buck, M.R., Karustis, D.G., Day, N.A., Honn, K.V. and Sloane, B.F. (1992) Degradation of Extracellular-Matrix Proteins by Human Cathepsin B from Normal and Tumor Tissues. Biochemical Journal, 282, 273-278.

[80]   Premzl, A., Zavasnik-Bergant, V., Turk, V. and Kos, J. (2003) Intracellular and Extracellular Cathepsin B Facilitate Invasion of MCF-10A neoT Cells through Reconstituted Extracellular Matrix in Vitro. Experimental Cell Research, 283, 206-214.

[81]   Miyake, H., Hara, I. and Eto, H. (2004) Serum Level of Cathepsin B and Its Density in Men with Prostate Cancer as Novel Markers of Disease Progression. Anticancer Research, 24, 2573-2577.

[82]   Podgorski, I. and Sloane, B.F. (2003) Cathepsin B and Its Role(s) in Cancer Progression. Biochemical Society Symposia, 70, 263-276.

[83]   Podgorski, I., Linebaugh, B.E., Sameni, M., Jedeszko, C., Bhagat, S., Cher, M.L. and Solane, B.F. (2005) Bone Micro-environment Modulates Expression and Activity of Cathepsin B in Prostate Cancer. Neoplasia, 7, 207-223.

[84]   Withana, N.P., Blum, G., Sameni, M., Slaney, C., Anbalagan, A., Olive, M.B., Bidwell, B.N., Edgington, L., Wang, L., Moin, K., Sloane, B.F., Anderson, R.L., Bogyo, M.S. and Parker, B.S. (2012) Cathepsin B Inhibition Limits Bone Metastasis in Breast Cancer. Cancer Research, 72, 1199-1209.

[85]   Skehan, P., Storeng, R., Scudiero, D., Monks, A., McMahon, J., Vistica, D., Warren, J.T., Bokesch, H., Kenney, S. and Boyd, M.R. (1990) New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening. Journal of the National Cancer Institute, 82, 1107-1112.